Mark Bradley

Professor Bradley’s major research is on the synthesis of ‘smart’ reagents designed to interrogate specific biological processes.

He is an inventor of 15 patents and has a significant history of company formation being a co-founder of Ilika Technologies in 2004 which floated on AIM in May 2010 and the University of Edinburgh spinout company Destina (2010) – now based in Granada following corporate investment. He is director of a £10M EPSRC funded project on Optical Molecular Imaging and Sensing

Mark Bradley